Read up before you level up.
Evidence-based articles from our clinical team — what the medications actually do, what to expect, and how to get the most from your protocol.
FeaturedThe science behind GLP-1: Why tirzepatide & semaglutide actually work
Inside the dual-hormone mechanism that's reshaping how clinicians approach sustainable weight loss — and what real members are seeing on the scale.
Recent articles
NAD+ explained: The cellular battery that fades with age
Why NAD+ matters for mitochondrial energy, DNA repair, and the sirtuin pathways linked to healthy aging — plus what restorative dosing actually feels like.
Glutathione: Your liver's favorite antioxidant
How the body's master antioxidant supports phase II detox, neutralizes oxidative stress, and gradually brightens skin tone from the inside out.
B12 + Lipo injections: The metabolism stack that punches above its weight
Why Methyl B12 and Lipo+B12 keep showing up in successful weight-loss and energy protocols — and who benefits most from adding them.
What to expect in your first month on a GLP-1
A week-by-week guide to the appetite changes, side-effect patterns, and habits that set you up for steady, sustainable progress.
Building a longevity stack: NAD+, glutathione, and B12 together
How three of the most-requested longevity injections complement each other — and a sample weekly cadence members actually run.
Insulin resistance: The hidden driver of stubborn weight
Why the scale won't budge even when you're doing everything right — and how GLP-1s, movement, and meal timing flip the metabolic switch.
GLP-1 drugs linked to 41% lower obesity-related cancer risk
A large study of over 229,000 people found semaglutide and tirzepatide were associated with dramatically reduced risk of endometrial, pancreatic, colorectal, and multiple myeloma cancers.